rs138519829

Variant summary

Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_006206.6(PDGFRA):​c.2778C>T​(p.Tyr926=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00308 in 1,604,072 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 24 hom. )

Consequence

PDGFRA
NM_006206.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.371
Variant links:
Genes affected
PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 4-54289012-C-T is Benign according to our data. Variant chr4-54289012-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 220817.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54289012-C-T is described in Lovd as [Benign]. Variant chr4-54289012-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.371 with no splicing effect.
BS2
High AC in GnomAd4 at 551 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PDGFRANM_006206.6 linkuse as main transcriptc.2778C>T p.Tyr926= synonymous_variant 21/23 ENST00000257290.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PDGFRAENST00000257290.10 linkuse as main transcriptc.2778C>T p.Tyr926= synonymous_variant 21/231 NM_006206.6 P1P16234-1

Frequencies

GnomAD3 genomes
AF:
0.00364
AC:
553
AN:
152090
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0302
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00288
Gnomad OTH
AF:
0.000959
GnomAD3 exomes
AF:
0.00416
AC:
1044
AN:
251196
Hom.:
10
AF XY:
0.00429
AC XY:
582
AN XY:
135758
show subpopulations
Gnomad AFR exome
AF:
0.000431
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00242
Gnomad FIN exome
AF:
0.0291
Gnomad NFE exome
AF:
0.00264
Gnomad OTH exome
AF:
0.00326
GnomAD4 exome
AF:
0.00303
AC:
4393
AN:
1451864
Hom.:
24
Cov.:
29
AF XY:
0.00300
AC XY:
2172
AN XY:
722998
show subpopulations
Gnomad4 AFR exome
AF:
0.000451
Gnomad4 AMR exome
AF:
0.000537
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00247
Gnomad4 FIN exome
AF:
0.0286
Gnomad4 NFE exome
AF:
0.00225
Gnomad4 OTH exome
AF:
0.00211
GnomAD4 genome
AF:
0.00362
AC:
551
AN:
152208
Hom.:
6
Cov.:
32
AF XY:
0.00462
AC XY:
344
AN XY:
74396
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.0302
Gnomad4 NFE
AF:
0.00287
Gnomad4 OTH
AF:
0.000949
Alfa
AF:
0.00227
Hom.:
1
Bravo
AF:
0.00119
Asia WGS
AF:
0.00115
AC:
5
AN:
3478
EpiCase
AF:
0.00311
EpiControl
AF:
0.00178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingGeneDxJan 12, 2021- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024PDGFRA: BP4, BP7 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Gastrointestinal stromal tumor Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not specified Benign:1
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Idiopathic hypereosinophilic syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hereditary cancer-predisposing syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 19, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
0.35
DANN
Benign
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138519829; hg19: chr4-55155179; COSMIC: COSV57270746; API